Tonghua Dongbao Pharmaceutical Co., Ltd. (SHA: 600867)
China flag China · Delayed Price · Currency is CNY
8.34
-0.35 (-4.03%)
Nov 22, 2024, 3:00 PM CST

Tonghua Dongbao Pharmaceutical Company Description

Tonghua Dongbao Pharmaceutical Co., Ltd. researches and develops, manufactures, and sells pharmaceutical for the treatment of diabetes, endocrine, and cardiovascular and cerebrovascular diseases products in China.

The company operates through Pharmaceutical Industry; Building Materials Industry; and Real Estate Industry segments.

It offers human insulin raw materials and injection, insulin glargine raw materials and injection, insulin aspart API and injection, Zhennaoning capsules, and diabetes-related medical devices.

Further, it provides insulin pen and needle injection system, blood sugar monitoring system, and online and offline patient management system.

It offers building materials.Tonghua Dongbao Pharmaceutical Co., Ltd. was founded in 1985 and is based in Tonghua, China.

Tonghua Dongbao Pharmaceutical Co., Ltd.
Country China
Founded 1985
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 3,196
CEO Sheng Leng Chun

Contact Details

Address:
Dongbao New Village
Tonghua, 134123
China
Phone 86 43 5508 8025
Website thdb.com

Stock Details

Ticker Symbol 600867
Exchange Shanghai Stock Exchange
Fiscal Year January - December
Reporting Currency CNY
ISIN Number CNE000000H87
SIC Code 2834

Key Executives

Name Position
Sheng Leng Chun GM and Director
Junyu Chi Chief Accountant
Hong Chen Chief Engineer and Deputy GM
Guodong Zhang Deputy GM and Director
Wenhai Zhang Deputy GM and Director
Zhiqiang Du Deputy General Manager
Fan Su Deputy GM and Board Secretary